Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 2
1(50.0%)
2Total
N/A(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03850457Completed

Epidemiological Study for Bronchopulmonary Dysplasia (BPD) in China

Role: collaborator

NCT02026882Not ApplicableCompleted

Supreme LMA Use in Urgent Caesarean Section

Role: lead

NCT01503801Phase 2Completed

Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia

Role: collaborator

All 3 trials loaded